Powerpoint Presentation
-
Upload
caroline-morris -
Category
Documents
-
view
123 -
download
0
Transcript of Powerpoint Presentation
The Synthesis of NPFF Receptor Ligand
A dual-acting compound with opioid agonist & neuropeptide FF
antagonist
Introduction
Caroline Morris
Hernando, MSUniversity of Mississippi
Undergraduate JuniorB.S in Pharmaceutical Sciences,
pursuing Pharm.D
Table of Contents1. Background
2. Projected Solution
3. Methodology
4. Conclusion
5. Personal Development
6. Acknowledgements
7. Questions
Background
• Chronic pain affects 116 million Americans per year 1
• Opioid drugs are the primary prescribed pain-killers
1O’Reilly, Kevin B. American Medical News. 2011
Background
• Opioid drugs have several side effects:- digestive problems2
- addiction3
- tolerance3
As the dosage increases, the side effects increase until the point that the side effects outweigh the benefits
2Chan, Lingtak-Neander. Nutrition Issues in Gastroenterology. 20083Stuckert, Jeffery. Psych Central. 2011
Projected Solution
• Previous research has discovered that the Neuropeptide FF antagonist receptors can prevent morphine-induced tolerance
• The use of a dual-acting compound with Opioid & NPFF receptors looks promising:
-opioid drug use without tolerance
Projected Solution
1. VBJ192 works- warm-water immersion test
Projected Solution
2. Blood-Brain Barrier
3. Structure-Activity Relationship (SAR)
Projected Solution
• Amidine functional groupcan penetrate the blood-brain barrier
• Similarities to VBJ192
Methodology
1. Synthesis of Benzyltriphenylphosphonium salt
A: 1 mole, B: 1 mole, C: 97% yield
A B C
Methodology
2. Wittig Reaction
A B
A: 34.62mmol, LDA: 38.06mmol, 1-benzylpiperidin-4-one: 6.7mL, B: 42.2% yield
Methodology
3. Bromination
A B
A: 5.58mmol, Br2: 8.37mmol, NaOH: 21.63mmol, B: 80.7% yield
Methodology
4. Suzuki Coupling
A B C
A: 5.23mmol, B: 6.28mmol, Pd(PPh3)4: 0.1205g, K2CO3: 13.09mmol, C: 52.1% yield
Methodology
5. Garigipati Reaction

A B
A: 0.275mmol, NH4Cl: 0.495mmol, Al(CH3)3: 0.458mmol, B: 56% yield
Methodology
1. Filtration 2. Column Chromatography
Methodology
• Because this synthesis required multiple steps, after each step, verification had to take place in before starting the next reaction
-in order to determine it was actually the desired product-make sure there were no impurities
Methodology
Thin Layer Chromatography (TLC)- used to determine Rf value
Rf value = distance product traveled distance solvent traveled = 6.25 cm
8.00 cm = 0.781
Methodology
TLC is also used to make comparisons:-the compound is the same across, verifying that the different tubes from column chromatography contain the same compound.
Methodology
-Bromination was successful! -Suzuki was successful!
Mass Spectrometry (MS)-verifies the mass of the compound
Conclusion
• We successfully modified VBJ192 into an amidine derivative• NMR verified
• Pharmacological evaluation will be performed on this compound
Personal Development
1. Honed research/lab skills2. Delved into Medicinal Chemistry3. Application of prior information4. Patience
Acknowledgements
Dr. Christopher McCurdyDr. Coco Kapanda
Kelsey LueckeDr. Velvet JourniganDr. Stephen Cutler
COBRE Grant P20GM104932
Questions
Wittig Mechanism
Bromination
Suzuki
Garigipati